Extract Technology
Private Company
Total funding raised: $2M
Overview
Founded in 1998 and headquartered in Leeds, UK, Extract Technology is a specialized provider of engineering solutions for high-containment and aseptic processing. Its core business revolves around designing and manufacturing isolators (both negative pressure for operator protection and positive pressure for product sterility), modular cleanrooms, and nuclear gloveboxes, serving global pharmaceutical and chemical clients. Following its 2021 acquisition by the Swiss-based Dec Group, the company operates as part of a larger global entity, leveraging expanded capabilities to offer end-to-end process solutions while maintaining its brand and focus on innovation in protection.
Technology Platform
Design and manufacturing of modular containment isolators (negative pressure for operator protection) and aseptic isolators (positive pressure for product protection), mobile cleanrooms, nuclear gloveboxes, and associated after-sales services.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Extract Technology competes in a fragmented global market with large diversified equipment providers (e.g., Getinge, Syntegon) and specialized containment firms. Its differentiation lies in deep engineering expertise for bespoke solutions, a broad product range from containment to aseptic to nuclear, and the strategic backing and global reach of the Dec Group platform.